GREENFIELD, Ind., July 30,
2024 /PRNewswire/ -- Elanco Animal Health
Incorporated (NYSE: ELAN) today released its 2023 Environmental,
Social and Governance (ESG) Report, showcasing its dedication to
advancing its four intertwined Healthy Purpose™ Pillars: Healthier
Animals, Healthier People, Healthier Planet and Healthier
Enterprise. The report highlights internal initiatives and
strategic external partnerships that are foundational to Elanco's
Healthy Purpose and demonstrate that healthier animals can
positively impact major global issues like food security, mental
health, social isolation and environmental sustainability.
Additionally, the company has refreshed its Sustainability
Accounting Standards Board (SASB) and Taskforce on Climate-related
Financial Disclosure (TCFD) reports, as well as its extensive suite
of issue briefs covering leading ESG topics and KPIs, to reflect
2023 data.
"As we celebrate our 70th anniversary, we're encouraged by the
progress our global team has made to continue to raise the bar on
our sustainability efforts. Our efforts are embedded across the
business to reduce our footprint, increase the expectations of our
supply chain, and deeply engage our people in our purpose, allowing
us to mitigate some of the most material risks for our business,"
said Jeff Simmons, Elanco President
and CEO. "We also view sustainability as more than a risk
mitigator, for Elanco, it's a competitive advantage, as we launch
innovations that transform animal care for our customers and bring
tools to help the environment. From the first treatment for
parvovirus – one of the deadliest diseases in puppies – to
pioneering new products and helping build marketplaces that support
emissions reduction goals, our team members around the world are
contributing to support healthier animals and a healthier, more
sustainable world."
In 2023, Elanco refreshed its ESG materiality assessment, in
alignment with the GRI Standards, IFRS Sustainability Disclosure
Standards and European Sustainability Reporting Standards (ESRS),
as a foundation for alignment with emerging ESG reporting
requirements around the world. The output of the assessment is
summarized in the 2023 report, including the impacts, risks,
opportunities and managerial approaches by strategic focus
area.
In 2023, Elanco advanced key programs and initiatives focused
on delivering on the four pillars of Elanco's Healthy
Purpose:
Healthier animals: Elanco made strides in developing
industry leading innovations that enhance the quality of life and
health of pets, strengthening the bond between humans and animals,
while also broadly delivering the programs and processes that
support humans and the animals within their care. 2023 key
initiatives included:
- Launched our "Defend Puppies. Defeat Parvo." initiative to
enhance awareness of and education about canine parvovirus, while
increasing veterinarian access to our canine parvovirus monoclonal
antibody (CPMA) through the establishment of the Elanco's Defenders
Fund, offering up to $1 million in
rebate incentives to veterinarians who purchase CPMA to help treat
the disease.
- Launched AdTab® (lotilaner), a non-prescription oral
monthly flea and tick product for both dogs and cats approved by
the European Medicines Agency (EMA), increasing accessibility and
convenience for pet owners by offering AdTab in European
pharmacies, pet shops and online.
- Expanded our Elanco Knowledge Solutions (EKS) offering for
dairy producers by introducing Dairy Data Access System (DDAS)
Plus, a farm-level analytics platform that provides weekly reports
across key areas of health and milk production, supporting decision
making for producers.
Healthier People: Elanco remained committed to delivering
positive impact on global communities, supporting small-scale
producers in Nigeria and
Uganda, while driving progress in
food security and human health. 2023 key initiatives included:
- Acquired the marketed product portfolio for NutriQuest® and in
2023 began bringing these nutritional products to new markets,
expanding our portfolio of antibiotic alternatives and delivering
expanded portfolio options to our customers.
- Launched Elanco's Dairy Antibiogram (DAB) initiative — a
collaboration between Elanco and New
Zealand dairy farms – to enhance farmers' ability to select
the most appropriate antimicrobial to treat mastitis in dairy cows,
a painful udder infection that can be caused by a number of
different pathogens.
- Piloted Tick Academy, an educational mobile app for farmers
that presents content on integrated tick management, as well as
contact information for nearby service providers and licensed
veterinary retailers in support of Elanco's Managing Animal Health
and Acaricides for Better Africa (MAHABA) initiative in
Uganda.
Healthier Planet: Elanco constantly pushes boundaries,
developing innovative products that tackle some of the world's most
pressing challenges. From pioneering solutions that measure,
reduce, and monetize our customer's carbon emissions on the farm,
to minimizing the Company's operational environmental footprint.
2023 key initiatives included:
- 12% of electricity use is from renewable sources, progressing
toward our 2030 goal of 100%.
- Reused or recycled 91% of waste generated by the company,
including production wastewater.
- Published a Sustainable Packaging Guideline, to outline the key
elements of Elanco's sustainable packaging program and
describe where and how sustainability considerations influence
engineering, design and sourcing decisions related to product
packaging.
- Helped U.S. dairy and beef customers avoid an estimated
2.3 million metric tons of greenhouse gas (GHG) emissions
(CO2e) through the use of Rumensin® in 2023.
Cumulatively (2020-2023), Elanco has helped customers avoid an
estimated 9.5 million metric tons of emissions with Rumensin,
approximately equivalent to taking more than 2.2 million passenger
cars off the road for a year.
Healthier Enterprise: Elanco supports hundreds of
global grassroots causes through an industry-leading employee
volunteer and giving program, while also creating inclusive
and safe environments where every colleague can grow personally and
professionally. 2023 key initiatives include:
- Became a participant in the U.N. Global Compact,
furthering Elanco's commitment to fundamental business principles
involving human rights, labor, anti-corruption and the
environment.
- Contributed more than 23,600 employee volunteer hours to the
global community, with an estimated value of $790,000 – up from approximately 12,800 hours in
2022.
- Achieved 28% employee participation in giving and
volunteerism.
- Committed $3.7 million in
corporate, Foundation and employee charitable and community
giving.
- Increased year-over-year participation in an optional employee
development program, Everyone LEADS, by 49%.
For details on the company's ESG disclosures, issue briefs,
policies, and programs, visit elanco.com/en-us/sustainability.
ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global
leader in animal health dedicated to innovating and delivering
products and services to prevent and treat disease in farm animals
and pets, creating value for farmers, pet owners, veterinarians,
stakeholders and society as a whole. With nearly 70 years of animal
health heritage, we are committed to helping our customers improve
the health of animals in their care, while also making a meaningful
impact on our local and global communities. At Elanco, we are
driven by our vision of Food and Companionship Enriching Life and
our Elanco Healthy Purpose – all to advance the health of animals,
people, the planet and our enterprise. Learn more at
www.elanco.com
Investor Contact: Katy Grissom
(317) 273-9248 kathryn.grissom@elancoah.com
Media Contact: Colleen Parr Dekker
(317) 989-7011 colleen.dekker@elancoah.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/elanco-releases-2023-environmental-social-and-governance-report-delivering-healthier-outcomes-for-animals-people-planet-and-enterprise-302209807.html
SOURCE Elanco Animal Health